← Back to news

S

Seeking Alpha: News RSS Feed

Vir Biotechnology launches $200M public stock offering

Trump to call for new tax cuts in SOTU - reports

Trex Non-GAAP EPS of $0.04 beats by $0.05, revenue of $161M beats by $16.62M

BridgeBio Pharma GAAP EPS of -$1.00 misses by $0.33, revenue of $154.2M beats by $5.13M

Day One Biopharmaceuticals reports Q4 results

Axon Enterprise Non-GAAP EPS of $2.15 beats by $0.55, revenue of $796.72M beats by $41.43M

Tempus AI Non-GAAP EPS of -$0.04 beats by $0.01, revenue of $367.2M beats by $3.81M

Shoals targets $560M–$600M 2026 revenue amid record backlog and new product launches

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

Boaz Weinstein sounds the alarm on private credit: 'the wheels are coming off'

Cheniere Energy cut at Morgan Stanley, turning cautious as global LNG market moves into oversupply

Tennant targets $250M AMR revenue by 2028 as ERP challenges reshape 2026 outlook

Primoris outlines $5.35–$5.55 EPS guidance for 2026 amid record $11.9B backlog and energy market growth

Henry Schein outlines 2026 EPS growth target of 5%–8% and strategic initiatives amid leadership transition

Diamondback signals Barnett ramp-up with 900 locations, targeting cost reductions and development acceleration

Boise Cascade outlines $45M–$55M Q1 EBITDA target for BMD amid leadership transition and continued margin focus

Accenture offers AI opportunity after selloff, UBS says

PPL raised at Barclays, set up for constructive Pennsylvania rate case

NexPoint Residential outlines 2026 core FFO guidance range of $2.42-$2.71 per share amid Sun Belt market inflection expectations

Payoneer applies for U.S. national bank charter

UFP Industries targets $100M Deckorators sales jump in 2026 as capacity expands, cost savings accelerate

Oncolytics Biotech gains as enrollments for GIT cancer trial conclude

Embraer unveils upgraded Praetor jets to tap strong business aviation demand

Westlake Chemical Partners signals distributable cash flow recovery in 2026 with no planned turnarounds

Rio Tinto downgraded at Barclays with 'headwinds incoming'

Number of banks in 'Problem Bank List' rises in Q4 2025 - FDIC

U.S. private school tuition nears $50K as costs climb, boarding programs face pressure

Ovintiv outlines return of 75% free cash flow to shareholders in 2026 as portfolio transformation completes

Repligen outlines $810M–$840M 2026 revenue target while expanding analytics and protein franchises

NRG targets 14% annual EPS growth through 2030 as LS Power integration outperforms

Hegseth gives Anthropic deadline to remove safeguards; threatens use of Defense Production Act: report

ACV Auctions falls to record low as profit outlook rattles Wall Street

Protara falls after mid-stage trial data for lead asset in bladder cancer

IBM's Anthropic-induced sell-off overlooks the fact it's disrupting itself: Jefferies

Seaport turns bullish on Fox as stock pullback post-earnings 'overdone'

Lineage Q4 2025 Earnings Preview

Immunocore Q4 2025 Earnings Preview

Hippo Holdings Q4 2025 Earnings Preview

Compania Cervecerias Unidas S.A. Q4 Earnings Preview

Grupo Aeroportuario Q4 2025 Earnings Preview

Fidelity National projects 30% revenue growth in 2026 as it doubles down on AI and banking innovation

Xometry outlines at least 21% revenue growth for 2026 with leadership transition and expanding enterprise adoption

Leonardo DRS targets 6%-8% organic revenue growth in 2026 while ramping investment in innovation and capacity

What’s next for Blue Owl after the private credit storm?

Kuwait seeking BlackRock, Brookfield for potential $7B oil pipeline deal - Reuters

Pfizer wins full FDA approval for Braftovi in colorectal cancer

Auto sales are forecast by Cox Automotive to remain sluggish

Shell, Cosan set to add capital into Brazilian sugar and ethanol JV - Bloomberg

Sotera Health outlines 2026 revenue growth target of up to 6.5% while advancing X-ray facility and margin expansion

Federal Signal Q4 2025 Earnings Preview